PMID- 17952633 OWN - NLM STAT- MEDLINE DCOM- 20080204 LR - 20211020 IS - 0895-8696 (Print) IS - 0895-8696 (Linking) VI - 33 IP - 3 DP - 2007 TI - Alpha-MSH rescues neurons from excitotoxic cell death. PG - 239-51 AB - This study investigates the effects of alpha-melanocyte-stimulating hormone (alpha-MSH), on neurodegeneration, gliosis and changes in the neurotrophic protein brain-derived neurotrophic factor (BDNF) and in pro-inflammatory cytokines, following kainic acid (KA)-induced excitotoxic damage in the rat. Male Sprague-Dawley rats were treated with alpha-MSH (intraperitoneally, i.p.) at 20 min, and 24 and 48 h following administration of 10 mg/kg KA (i.p.). The animals were sacrificed at 30 min, 4 h, 24 h and 72 h after KA-administration and the levels of interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) were analysed in samples of hippocampus and hypothalamus. Levels of BDNF were analysed in the hippocampus. Stereological quantification showed a markedly reduced number of viable neurons in the CA1 pyramidal cell layer upon KA-administration as compared to animals injected with vehicle (p < 0.05, 79,587 +/- 25,554 vs. 145,254 +/- 27,871). The number of viable neurons upon administration of alpha-MSH was significantly higher than upon KA alone (p < 0.05, 119,776 +/- 33,158, KA+alpha-MSH vs. 79,587 +/- 27,554, KA + Saline). Astrocyte activation due to the KA-induced excitotoxicity was reduced, and the KA-induced increase in IL-1beta levels was delayed by the treatment with alpha-MSH. In conclusion, the degree of reduction in cell viability in the hippocampus CA1 pyramidal cell layer upon KA-induced excitotoxicity was similar to that seen previously upon global cerebral ischaemia. Furthermore, the administration of alpha-MSH resulted in a similar increase in cell viability, supporting the hypothesis that administration of alpha-MSH has rescuing effects on neurons subjected to excitotoxic insults. FAU - Forslin Aronsson, Asa AU - Forslin Aronsson A AD - Division of Neurodegeneration and Neuroinflammation, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, SE-141 86 Stockholm, Sweden. FAU - Spulber, Stefan AU - Spulber S FAU - Oprica, Mircea AU - Oprica M FAU - Winblad, Bengt AU - Winblad B FAU - Post, Claes AU - Post C FAU - Schultzberg, Marianne AU - Schultzberg M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070417 PL - United States TA - J Mol Neurosci JT - Journal of molecular neuroscience : MN JID - 9002991 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Cytokines) RN - 0 (Excitatory Amino Acid Agonists) RN - 0 (Neuroprotective Agents) RN - 581-05-5 (alpha-MSH) RN - SIV03811UC (Kainic Acid) SB - IM MH - Animals MH - Astrocytes/cytology/metabolism MH - Body Temperature MH - Brain-Derived Neurotrophic Factor/metabolism MH - *Cell Death MH - Cytokines/metabolism MH - Excitatory Amino Acid Agonists/*toxicity MH - Hippocampus/cytology/metabolism MH - Hypothalamus/cytology/metabolism MH - Kainic Acid/*toxicity MH - Male MH - Neurons/cytology/metabolism MH - Neuroprotective Agents/*metabolism MH - Rats MH - Rats, Sprague-Dawley MH - alpha-MSH/*metabolism EDAT- 2007/10/24 09:00 MHDA- 2008/02/05 09:00 CRDT- 2007/10/24 09:00 PHST- 2006/10/06 00:00 [received] PHST- 2006/10/10 00:00 [accepted] PHST- 2007/10/24 09:00 [pubmed] PHST- 2008/02/05 09:00 [medline] PHST- 2007/10/24 09:00 [entrez] AID - 10.1007/s12031-007-0019-2 [doi] PST - ppublish SO - J Mol Neurosci. 2007;33(3):239-51. doi: 10.1007/s12031-007-0019-2. Epub 2007 Apr 17.